Every year, the Centers for Medicare and Medicaid Services issues a "call letter" to lay out various policies and requirements for the coming program year within the Medicare program.
The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.
The Pharmacy Technician Certification Board is making changes to its certification program that it said would advance pharmacy tech certifications, the group announced.
The Supreme Court will hear arguments later this month in a case that could determine the future of many patent settlements between brand and generic drug makers.
The Consumer Healthcare Products Association on Friday released a statement regarding a poll released last week by the Asthma and Allergy Foundation of America.
The National Association of Chain Drug Stores has launched a mobile app for its upcoming 2013 Annual Meeting in Palm Beach, Fla., the retail pharmacy trade group said.
Pharmacy benefit managers are becoming increasingly adept at leveraging the power of generics to save client healthcare dollars and improve their own standing, reports indicated.
The battle over "pay for delay" continues to heat up, and its resolution likely won't come until the nation's highest court decides on the legality of the practice.
The Food and Drug Administration has set user fee rates for generic drug companies, the agency said Jan. 27.
Medicare and Medicaid are working with the private sector to create a roadmap for the future of healthcare delivery, and a congressional hearing was convened Thursday to ensure it does that.